2025年全球醫藥倉儲服務市場報告

預計未來幾年，藥品穩定性儲存服務市場規模將強勁成長。至2029年，該市場規模將成長至36.5億美元，複合年成長率為6.5%。預測期內的成長主要歸因於個人化醫療的興起、低溫運輸物流的擴展、生物製藥產品線的增加、生物製藥核准的增加以及穩定性測試需求的不斷成長。這段時期的主要趨勢包括技術進步、低溫儲存技術的進步、數位監控技術的發展、包裝技術的創新以及溫控儲存系統的進步。

預計未來新藥核准數量的增加將推動藥品穩定性儲存服務市場的擴張。新藥是指新開發的、過去未獲核准或上市的藥物化合物。新藥新藥認證數量的激增很大程度上得益於生物技術的進步，生物技術使得新化合物的發現成為可能，監管流程的改進也促進了更快、更有效率的藥物開發。新藥認證數量的增加將推動對藥品穩定性儲存服務的需求，這些服務旨在確保這些產品的適當條件、合規性和長期儲存管理。例如，美國食品藥物管理局(FDA) 在 2023 年 10 月報告稱，2022 年核准了37 種新藥，2024 年核准了50 種新藥，這將推動癌症、罕見疾病、神經病學、感染疾病、思覺失調症、疼痛、阿茲海默症疾病的治療。因此，新藥核准數量的增加正在推動藥品穩定性儲存服務市場的成長。

藥品穩定性儲存服務市場的主要企業正專注於開發技術先進的解決方案，例如低溫儲存套件，以延長對溫度敏感的藥品的保存期限。低溫儲存套件是專用設施，可維持極低的溫度，通常低於-150°C，以保存對溫度敏感的生物和藥物材料，例如細胞療法、疫苗和生技藥品。例如，2024 年 12 月，總部位於英國的穩定性和生物樣本儲存公司 Astoriom 宣佈在其位於愛爾蘭沃特福德郡的 Tramore 工廠建立一個低溫儲存套件。此次擴建將顯著提高生物樣本的儲存容量，並提供低至-196°C 的精確溫度控制、大儲存容量、符合法規的 ISO9001 認證以及門禁和監控系統等先進的安全功能，以確保安全的長期儲存。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球醫藥倉儲服務PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球醫藥穩定儲存服務市場：成長率分析
• 全球醫藥穩定性服務市場表現：規模與成長，2019-2024
• 全球藥物穩定性服務市場預測：規模與成長，2024-2029 年，2034 年
• 全球藥物穩定性服務總目標市場（TAM）

第6章市場區隔

• 全球醫藥倉儲服務市場：依服務、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 穩定
• 貯存
• 全球藥品穩定性服務市場：依產品類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 藥片
• 膠囊
• 注射液
• 口服懸浮液
• 組合產品
• 其他產品類型
• 全球藥物穩定性服務市場（依分子、實際及預測），2019-2024 年、2024-2029 年、2034 年
• 小分子
• 高分子
• 全球醫藥倉儲服務市場模式、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 內部
• 外包
• 全球醫藥儲存服務市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
• 生物製藥公司
• 契約製造組織
• 合約研究組織
• 其他最終用戶
• 全球醫藥穩定服務市場、穩定服務細分、按類型、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 長期穩定性測試
• 加速穩定性測試
• 中期穩定性測試
• 光穩定性測試
• 強制劣化研究
• 全球醫藥倉儲服務市場倉儲服務細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 常溫保存
• 冷藏保存（2度C至8度C）
• 冷凍保存（-20度C至-80度C）
• 低溫儲存（-150度C至-196度C）
• 管制物質和產品的儲存

第7章 區域和國家分析

• 全球醫藥倉儲服務市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球醫藥倉儲服務市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 藥品穩定儲存服務市場：競爭格局
• 藥品穩定儲存服務市場：公司簡介
  • Cencora Inc Overview, Products and Services, Strategy and Financial Analysis
  • SGS SA Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Intertek Group plc
• Element Materials Technology Inc
• Alloga UK Ltd.
• ALS Limited
• Pharmaceutical Contract Industries Pharma Services.
• Almac Group
• Alcami Corporation
• BioLife Solutions Inc.
• Auriga Research Private Limited
• Reading Scientific Services Ltd.
• Lucideon Limited
• Q Laboratories Inc
• PD Partners
• Precision Stability Storage
• Roylance Stability Storage Limited

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年藥品穩定儲存服務市場：提供新機會的國家
• 2029年藥品穩定儲存服務市場：細分市場帶來新機會
• 2029年藥品穩定儲存服務市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Pharmaceutical stability and storage services are specialized offerings designed to ensure that pharmaceutical products, including drugs, medications, and vaccines, retain their quality, efficacy, and safety throughout their shelf life. These services involve maintaining controlled storage environments, conducting stability studies to monitor chemical, physical, and microbiological changes, and ensuring compliance with regulatory standards.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary pharmaceutical stability and storage services include stability testing and storage solutions. Stability services evaluate how pharmaceutical products maintain their quality, potency, and safety under varying environmental conditions over time. These services apply to various products such as tablets, capsules, injectable solutions, oral suspensions, combination products, and others, and can involve both small and large molecules. Stability and storage services are provided through in-house and outsourcing models, and are utilized by biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and other entities.

The pharmaceutical stability and storage services market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical stability and storage services market statistics, including pharmaceutical stability and storage services industry global market size, regional shares, competitors with a pharmaceutical stability and storage services market share, detailed pharmaceutical stability and storage services market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical stability and storage services industry. This pharmaceutical stability and storage services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical stability and storage services market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth observed during the historic period can be attributed to the rising demand for biologics, the increasing prevalence of chronic diseases, growth in drug development, the growing complexity of drug formulations, and heightened research and development efforts within the pharmaceutical industry.

The pharmaceutical stability and storage services market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth projected during the forecast period can be attributed to the rise of personalized medicine, the expansion of cold chain logistics, a growing biopharma pipeline, increasing biologic drug approvals, and a higher demand for stability testing. Key trends during this period include technological advancements, progress in cryogenic storage technologies, developments in digital monitoring technologies, innovations in packaging technologies, and the advancement of temperature-controlled storage systems.

The growing number of novel drug approvals is expected to drive the expansion of the pharmaceutical stability and storage services market in the future. A novel drug is a newly developed pharmaceutical compound that has not been previously approved for use or marketed. The surge in novel drug approvals is largely attributed to advancements in biotechnology, which have enabled the discovery of new compounds, as well as improvements in regulatory processes that facilitate faster and more efficient drug development. The increase in novel drug approvals boosts the demand for pharmaceutical stability and storage services, which ensure the proper conditions, compliance, and extended shelf-life management of these products. For example, in October 2023, the U.S. Food and Drug Administration (FDA) reported that 37 novel drugs were approved in 2022, followed by 50 in 2024, advancing treatments in areas such as cancer, rare diseases, neurology, infections, and conditions such as schizophrenia, pain, and Alzheimer's. As such, the rising number of novel drug approvals is fueling the growth of the pharmaceutical stability and storage services market.

Leading companies in the pharmaceutical stability and storage services market are focusing on the development of technologically advanced solutions, such as cryogenic storage suites, to improve the preservation of temperature-sensitive pharmaceutical products. Cryogenic storage suites are specialized facilities that maintain extremely low temperatures, typically below -150°C, to preserve temperature-sensitive biological and pharmaceutical materials such as cell therapies, vaccines, and biologics. For instance, in December 2024, Astoriom, a UK-based stability and biospecimen storage company, unveiled a cryogenic storage suite at its Tramore facility in County Waterford, Ireland. This expansion significantly enhances its capacity to store biological samples, offering precise temperature control down to -196°C, large storage capacity, ISO 9001 certification for regulatory compliance, and advanced security features, such as access controls and monitoring systems, to ensure safe long-term preservation.

In June 2022, Cambrex Corporation, a US-based contract development and manufacturing organization, acquired Q1 Scientific for an undisclosed amount. This acquisition allows Cambrex to expand its presence in Europe, bolster its stability storage service capabilities, and strengthen its portfolio of outsourced pharmaceutical solutions to meet the growing demands of the industry. Q1 Scientific Limited, based in Ireland, specializes in providing pharmaceutical stability and storage services.

Major players in the pharmaceutical stability and storage services market are Cencora Inc, SGS S.A., Eurofins Scientific SE, Catalent Inc, Charles River Laboratories, Intertek Group plc, Element Materials Technology Inc, Alloga UK Ltd., ALS Limited, Pharmaceutical Contract Industries Pharma Services., Almac Group, Alcami Corporation, BioLife Solutions Inc., Auriga Research Private Limited, Reading Scientific Services Ltd., Lucideon Limited, Q Laboratories Inc, PD Partners, Precision Stability Storage, Roylance Stability Storage Limited.

North America was the largest region in the pharmaceutical stability and storage services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical stability and storage services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical stability and storage services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical stability and storage services market consists of revenues earned by entities by providing services such as photostability testing, cold chain management, disaster recovery and backup storage. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical stability and storage services market also includes sales of stability chambers, cryogenic storage systems, cold storage units and automated sample management systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Stability And Storage Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical stability and storage services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical stability and storage services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical stability and storage services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Stability; Storage
• 2) By Product Type: Tablets; Capsules; Injectable Solutions; Oral Suspensions; Combination Products; Other Product Types
• 3) By Molecule: Small Molecule; Large Molecule
• 4) By Mode: In-House; Outsourcing
• 5) By End User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Other End Users
• Subsegments:
• 1) Stability Services: Long-Term Stability Studies; Accelerated Stability Studies; Intermediate Stability Studies; Photostability Testing; Forced Degradation Studies
• 2) Storage Services: Ambient Storage; Refrigerated Storage (2°C to 8°C); Frozen Storage (-20°C to -80°C); Cryogenic Storage (-150°C to -196°C); Controlled Drug Substance And Product Storage
• Companies Mentioned: Cencora Inc; SGS S.A.; Eurofins Scientific SE; Catalent Inc; Charles River Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Stability And Storage Services Market Characteristics

3. Pharmaceutical Stability And Storage Services Market Trends And Strategies

4. Pharmaceutical Stability And Storage Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Stability And Storage Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Stability And Storage Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Stability And Storage Services Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Stability And Storage Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Stability And Storage Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Stability And Storage Services Total Addressable Market (TAM)

6. Pharmaceutical Stability And Storage Services Market Segmentation

• 6.1. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stability
• Storage
• 6.2. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Injectable Solutions
• Oral Suspensions
• Combination Products
• Other Product Types
• 6.3. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule
• Large Molecule
• 6.4. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-House
• Outsourcing
• 6.5. Global Pharmaceutical Stability And Storage Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Contract Research Organizations
• Other End Users
• 6.6. Global Pharmaceutical Stability And Storage Services Market, Sub-Segmentation Of Stability Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long-Term Stability Studies
• Accelerated Stability Studies
• Intermediate Stability Studies
• Photostability Testing
• Forced Degradation Studies
• 6.7. Global Pharmaceutical Stability And Storage Services Market, Sub-Segmentation Of Storage Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambient Storage
• Refrigerated Storage (2°C to 8°C)
• Frozen Storage (-20°C to -80°C)
• Cryogenic Storage (-150°C to -196°C)
• Controlled Drug Substance And Product Storage

7. Pharmaceutical Stability And Storage Services Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Stability And Storage Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Stability And Storage Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Stability And Storage Services Market

• 8.1. Asia-Pacific Pharmaceutical Stability And Storage Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Stability And Storage Services Market

• 9.1. China Pharmaceutical Stability And Storage Services Market Overview
• 9.2. China Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Stability And Storage Services Market

• 10.1. India Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Stability And Storage Services Market

• 11.1. Japan Pharmaceutical Stability And Storage Services Market Overview
• 11.2. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Stability And Storage Services Market

• 12.1. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Stability And Storage Services Market

• 13.1. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Stability And Storage Services Market

• 14.1. South Korea Pharmaceutical Stability And Storage Services Market Overview
• 14.2. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Stability And Storage Services Market

• 15.1. Western Europe Pharmaceutical Stability And Storage Services Market Overview
• 15.2. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Stability And Storage Services Market

• 16.1. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Stability And Storage Services Market

• 17.1. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Stability And Storage Services Market

• 18.1. France Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Stability And Storage Services Market

• 19.1. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Stability And Storage Services Market

• 20.1. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Stability And Storage Services Market

• 21.1. Eastern Europe Pharmaceutical Stability And Storage Services Market Overview
• 21.2. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Stability And Storage Services Market

• 22.1. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Stability And Storage Services Market

• 23.1. North America Pharmaceutical Stability And Storage Services Market Overview
• 23.2. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Stability And Storage Services Market

• 24.1. USA Pharmaceutical Stability And Storage Services Market Overview
• 24.2. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Stability And Storage Services Market

• 25.1. Canada Pharmaceutical Stability And Storage Services Market Overview
• 25.2. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Stability And Storage Services Market

• 26.1. South America Pharmaceutical Stability And Storage Services Market Overview
• 26.2. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Stability And Storage Services Market

• 27.1. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Stability And Storage Services Market

• 28.1. Middle East Pharmaceutical Stability And Storage Services Market Overview
• 28.2. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Stability And Storage Services Market

• 29.1. Africa Pharmaceutical Stability And Storage Services Market Overview
• 29.2. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Stability And Storage Services Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Stability And Storage Services Market Competitive Landscape
• 30.2. Pharmaceutical Stability And Storage Services Market Company Profiles
  • 30.2.1. Cencora Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. SGS S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Stability And Storage Services Market Other Major And Innovative Companies

• 31.1. Intertek Group plc
• 31.2. Element Materials Technology Inc
• 31.3. Alloga UK Ltd.
• 31.4. ALS Limited
• 31.5. Pharmaceutical Contract Industries Pharma Services.
• 31.6. Almac Group
• 31.7. Alcami Corporation
• 31.8. BioLife Solutions Inc.
• 31.9. Auriga Research Private Limited
• 31.10. Reading Scientific Services Ltd.
• 31.11. Lucideon Limited
• 31.12. Q Laboratories Inc
• 31.13. PD Partners
• 31.14. Precision Stability Storage
• 31.15. Roylance Stability Storage Limited

32. Global Pharmaceutical Stability And Storage Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Stability And Storage Services Market

34. Recent Developments In The Pharmaceutical Stability And Storage Services Market

35. Pharmaceutical Stability And Storage Services Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Stability And Storage Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Stability And Storage Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Stability And Storage Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34925_Pharmaceutical_Stability_And_Storage_Services_GMR_2025